The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Bio-MEMS & Microfluidics Market Research Report 2025
Synopsis
Overall world revenue for Bio-MEMS and Microfluidics will have a strong revenue growth through to 2027.The increasing prevalence of neurological conditions, increase in diagnostic procedures in emerging economies and increasing ageing population will increase sales to 2027.
The global Bio-MEMS & Microfluidics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
There will be growth in both established and in developing countries. Our analyses show that the developing markets, China and India in particular, will continue to achieve high revenue growth to 2027. Developments worldwide in medical device regulation, especially in the US and Japan will influence the market.
This report aims to provide a comprehensive presentation of the global market for Bio-MEMS & Microfluidics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bio-MEMS & Microfluidics.
Report Scope
The Bio-MEMS & Microfluidics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bio-MEMS & Microfluidics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bio-MEMS & Microfluidics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Diagnostics
Nova Biomedical
Danaher
Thermo Fisher Scientific
Medtronic
Boston Scientific
ROCHE
Johnson & Johnson
Becton, Dickinson
Segment by Type
Implantable Bio-MEMS
Injectable Bio-MEMS
Other Devices
Segment by Application
Pharmaceutical Industry
Medical
Research Centres
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Bio-MEMS & Microfluidics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Overall world revenue for Bio-MEMS and Microfluidics will have a strong revenue growth through to 2027.The increasing prevalence of neurological conditions, increase in diagnostic procedures in emerging economies and increasing ageing population will increase sales to 2027.
The global Bio-MEMS & Microfluidics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
There will be growth in both established and in developing countries. Our analyses show that the developing markets, China and India in particular, will continue to achieve high revenue growth to 2027. Developments worldwide in medical device regulation, especially in the US and Japan will influence the market.
This report aims to provide a comprehensive presentation of the global market for Bio-MEMS & Microfluidics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bio-MEMS & Microfluidics.
Report Scope
The Bio-MEMS & Microfluidics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bio-MEMS & Microfluidics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bio-MEMS & Microfluidics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Diagnostics
Nova Biomedical
Danaher
Thermo Fisher Scientific
Medtronic
Boston Scientific
ROCHE
Johnson & Johnson
Becton, Dickinson
Segment by Type
Implantable Bio-MEMS
Injectable Bio-MEMS
Other Devices
Segment by Application
Pharmaceutical Industry
Medical
Research Centres
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Bio-MEMS & Microfluidics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bio-MEMS & Microfluidics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Implantable Bio-MEMS
1.2.3 Injectable Bio-MEMS
1.2.4 Other Devices
1.3 Market by Application
1.3.1 Global Bio-MEMS & Microfluidics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical Industry
1.3.3 Medical
1.3.4 Research Centres
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Bio-MEMS & Microfluidics Market Perspective (2019-2030)
2.2 Bio-MEMS & Microfluidics Growth Trends by Region
2.2.1 Global Bio-MEMS & Microfluidics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Bio-MEMS & Microfluidics Historic Market Size by Region (2019-2024)
2.2.3 Bio-MEMS & Microfluidics Forecasted Market Size by Region (2025-2030)
2.3 Bio-MEMS & Microfluidics Market Dynamics
2.3.1 Bio-MEMS & Microfluidics Industry Trends
2.3.2 Bio-MEMS & Microfluidics Market Drivers
2.3.3 Bio-MEMS & Microfluidics Market Challenges
2.3.4 Bio-MEMS & Microfluidics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bio-MEMS & Microfluidics Players by Revenue
3.1.1 Global Top Bio-MEMS & Microfluidics Players by Revenue (2019-2024)
3.1.2 Global Bio-MEMS & Microfluidics Revenue Market Share by Players (2019-2024)
3.2 Global Bio-MEMS & Microfluidics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Bio-MEMS & Microfluidics Revenue
3.4 Global Bio-MEMS & Microfluidics Market Concentration Ratio
3.4.1 Global Bio-MEMS & Microfluidics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bio-MEMS & Microfluidics Revenue in 2023
3.5 Bio-MEMS & Microfluidics Key Players Head office and Area Served
3.6 Key Players Bio-MEMS & Microfluidics Product Solution and Service
3.7 Date of Enter into Bio-MEMS & Microfluidics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Bio-MEMS & Microfluidics Breakdown Data by Type
4.1 Global Bio-MEMS & Microfluidics Historic Market Size by Type (2019-2024)
4.2 Global Bio-MEMS & Microfluidics Forecasted Market Size by Type (2025-2030)
5 Bio-MEMS & Microfluidics Breakdown Data by Application
5.1 Global Bio-MEMS & Microfluidics Historic Market Size by Application (2019-2024)
5.2 Global Bio-MEMS & Microfluidics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Bio-MEMS & Microfluidics Market Size (2019-2030)
6.2 North America Bio-MEMS & Microfluidics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Bio-MEMS & Microfluidics Market Size by Country (2019-2024)
6.4 North America Bio-MEMS & Microfluidics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Bio-MEMS & Microfluidics Market Size (2019-2030)
7.2 Europe Bio-MEMS & Microfluidics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Bio-MEMS & Microfluidics Market Size by Country (2019-2024)
7.4 Europe Bio-MEMS & Microfluidics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Bio-MEMS & Microfluidics Market Size (2019-2030)
8.2 Asia-Pacific Bio-MEMS & Microfluidics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Bio-MEMS & Microfluidics Market Size by Region (2019-2024)
8.4 Asia-Pacific Bio-MEMS & Microfluidics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Bio-MEMS & Microfluidics Market Size (2019-2030)
9.2 Latin America Bio-MEMS & Microfluidics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Bio-MEMS & Microfluidics Market Size by Country (2019-2024)
9.4 Latin America Bio-MEMS & Microfluidics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bio-MEMS & Microfluidics Market Size (2019-2030)
10.2 Middle East & Africa Bio-MEMS & Microfluidics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Bio-MEMS & Microfluidics Market Size by Country (2019-2024)
10.4 Middle East & Africa Bio-MEMS & Microfluidics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Diagnostics
11.1.1 Abbott Diagnostics Company Detail
11.1.2 Abbott Diagnostics Business Overview
11.1.3 Abbott Diagnostics Bio-MEMS & Microfluidics Introduction
11.1.4 Abbott Diagnostics Revenue in Bio-MEMS & Microfluidics Business (2019-2024)
11.1.5 Abbott Diagnostics Recent Development
11.2 Nova Biomedical
11.2.1 Nova Biomedical Company Detail
11.2.2 Nova Biomedical Business Overview
11.2.3 Nova Biomedical Bio-MEMS & Microfluidics Introduction
11.2.4 Nova Biomedical Revenue in Bio-MEMS & Microfluidics Business (2019-2024)
11.2.5 Nova Biomedical Recent Development
11.3 Danaher
11.3.1 Danaher Company Detail
11.3.2 Danaher Business Overview
11.3.3 Danaher Bio-MEMS & Microfluidics Introduction
11.3.4 Danaher Revenue in Bio-MEMS & Microfluidics Business (2019-2024)
11.3.5 Danaher Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Detail
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Bio-MEMS & Microfluidics Introduction
11.4.4 Thermo Fisher Scientific Revenue in Bio-MEMS & Microfluidics Business (2019-2024)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Medtronic
11.5.1 Medtronic Company Detail
11.5.2 Medtronic Business Overview
11.5.3 Medtronic Bio-MEMS & Microfluidics Introduction
11.5.4 Medtronic Revenue in Bio-MEMS & Microfluidics Business (2019-2024)
11.5.5 Medtronic Recent Development
11.6 Boston Scientific
11.6.1 Boston Scientific Company Detail
11.6.2 Boston Scientific Business Overview
11.6.3 Boston Scientific Bio-MEMS & Microfluidics Introduction
11.6.4 Boston Scientific Revenue in Bio-MEMS & Microfluidics Business (2019-2024)
11.6.5 Boston Scientific Recent Development
11.7 ROCHE
11.7.1 ROCHE Company Detail
11.7.2 ROCHE Business Overview
11.7.3 ROCHE Bio-MEMS & Microfluidics Introduction
11.7.4 ROCHE Revenue in Bio-MEMS & Microfluidics Business (2019-2024)
11.7.5 ROCHE Recent Development
11.8 Johnson & Johnson
11.8.1 Johnson & Johnson Company Detail
11.8.2 Johnson & Johnson Business Overview
11.8.3 Johnson & Johnson Bio-MEMS & Microfluidics Introduction
11.8.4 Johnson & Johnson Revenue in Bio-MEMS & Microfluidics Business (2019-2024)
11.8.5 Johnson & Johnson Recent Development
11.9 Becton, Dickinson
11.9.1 Becton, Dickinson Company Detail
11.9.2 Becton, Dickinson Business Overview
11.9.3 Becton, Dickinson Bio-MEMS & Microfluidics Introduction
11.9.4 Becton, Dickinson Revenue in Bio-MEMS & Microfluidics Business (2019-2024)
11.9.5 Becton, Dickinson Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
